PRME FY 2020 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$2M42.8% margin

Operating Income

-$932,000-17.9% margin

Net Income

-$3M-65.5% margin

EPS (Diluted)

$-0.05

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$391,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$21M

Stockholders' Equity

$33M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$0	—
Gross Profit	$2M	-$3M	+180.8%
Operating Income	-$932,000	-$2M	+57.1%
Net Income	-$3M	-$3M	-34.8%